Evaluation of Satisfaction in Patients Receiving PegIntron Pen / Rebetol for Hepatitis C
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 185
- 主要终点
- Satisfaction of Patients Receiving PegIntron Pen Plus Rebetol Therapy, Assessed by a Survey.
研究概览
简要总结
The objective of this study is to evaluate patient satisfaction in hepatitis C patients receiving PegIntron pen plus Rebetol. The rationale is that the effectiveness of treatment is correlated with adherence to the prescribed regimen which, in turn, is affected by the ease of use and accuracy of treatment administration. Since the PegIntron pen is a novel device, the results of this study will be used to improve the training of patients and healthcare providers in PegIntron pen use.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with hepatitis C under treatment with PegIntron Pen and Rebetol in Romania.
排除标准
- •Not applicable
研究组 & 干预措施
All Treated Patients
All patients participating in the study.
干预措施: PegIntron (peginterferon alfa-2b; SCH 54031) pen (Biological)
All Treated Patients
All patients participating in the study.
干预措施: Rebetol (ribavirin; SCH 18908) (Drug)
结局指标
主要结局
Satisfaction of Patients Receiving PegIntron Pen Plus Rebetol Therapy, Assessed by a Survey.
时间窗: The survey was administered during a follow-up visit in the clinic, at any point during the 48-week treatment.
The scale used in the patient questionnaire ranged from 0 (dissatisfied) to 8 (very satisfied). Patients evaluated the training received from the medical staff, ease of the preparation and administration of the medication, and the personal experience when using the PegIntron pen.
次要结局
未报告次要终点